loadpatents
name:-0.037183046340942
name:-0.01216721534729
name:-0.00046110153198242
TRUNK; Michael Patent Filings

TRUNK; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for TRUNK; Michael.The latest application filed is for "stable powder formulation containing an anticholingeric agent".

Company Profile
0.12.34
  • TRUNK; Michael - Ingelheim am Rhein DE
  • Trunk; Michael - Ingelheim N/A DE
  • Trunk; Michael - Ingenlheim DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Stable Powder Formulation Containing An Anticholingeric Agent
App 20170326150 - TRUNK; Michael ;   et al.
2017-11-16
Stable Powder Formulation Containing An Anticholingeric Agent
App 20160263121 - TRUNK; Michael ;   et al.
2016-09-15
Micronization method
Grant 9,156,835 - Rasenack , et al. October 13, 2
2015-10-13
Stable Powder Formulation Containing An Anticholingeric Agent
App 20130164344 - TRUNK; Michael ;   et al.
2013-06-27
Encapsulated tiotropium containing powder formulation for inhalation
Grant 8,197,845 - Hartig , et al. June 12, 2
2012-06-12
Blister For Inhalers
App 20110061652 - KRUEGER; Michael ;   et al.
2011-03-17
Radiolabelled Microparticles, Processes For The Preparation Thereof And The Use Thereof
App 20100272638 - HARTIG; Mareke ;   et al.
2010-10-28
Powder Formulations For Inhalation Containing Enantiomerically Pure Beta-agonists
App 20100233268 - Trunk; Michael ;   et al.
2010-09-16
Micronization Method
App 20100215590 - Rasenack; Norbert ;   et al.
2010-08-26
Novel Powderous Medicaments Comprising Tiotropium and Salmeterol and Lactose as Carrier
App 20100189780 - Walz; Michael ;   et al.
2010-07-29
Tiotropium containing powder formulation for inhalation
Grant 7,763,280 - Hartig , et al. July 27, 2
2010-07-27
Powdered inhalants based on modified lactose mixtures as excipient
Grant 7,736,628 - Mueller , et al. June 15, 2
2010-06-15
Stable powder formulation containing an anticholinergic agent
App 20100055193 - Trunk; Michael ;   et al.
2010-03-04
Stable powder formulation containing a novel anticholinergic agent
App 20100047359 - Trunk; Michael ;   et al.
2010-02-25
Surface modification of lactose excipient for use in powders for inhalation
Grant 7,658,949 - Trunk , et al. February 9, 2
2010-02-09
Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
Grant 7,642,268 - Bender , et al. January 5, 2
2010-01-05
Tiotropium Containing Powder Formulation For Inhalation
App 20090311314 - Hartig; Mareke ;   et al.
2009-12-17
Capsules Containing Inhalable Tiotropium
App 20090137621 - Hochrainer; Dieter ;   et al.
2009-05-28
Anticholinergic powder formulations for inhalation
Grant 7,462,367 - Schmidt , et al. December 9, 2
2008-12-09
Inhalation Powder Containing the CGRP antagonist BIBN4096 and Process for the Preparation Thereof
App 20080038357 - Trunk; Michael ;   et al.
2008-02-14
Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
Grant 7,309,707 - Bender , et al. December 18, 2
2007-12-18
Crystalline Micronisate, Process for the Manufacture Thereof and Use Thereof for the Preparation of a Medicament
App 20070015785 - Bender; Helmut ;   et al.
2007-01-18
Inhalative powder formulations containing the CGRP-antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidin- yl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine
App 20060222599 - Trunk; Michael
2006-10-05
Blister for inhalers
App 20060134007 - Krueger; Michael ;   et al.
2006-06-22
Surface modification of lactose excipient for use in powders for inhalation
App 20060120970 - Trunk; Michael ;   et al.
2006-06-08
New powdered inhalants based on modified lactose mixtures as excipient
App 20060115432 - Mueller; Bernd Wilhelm ;   et al.
2006-06-01
Anticholinergic powder formulations for inhalation
App 20050226818 - Schmidt, Friedrich ;   et al.
2005-10-13
Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
App 20050147568 - Trunk, Michael ;   et al.
2005-07-07
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
Grant 6,908,928 - Banholzer , et al. June 21, 2
2005-06-21
Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
Grant 6,900,317 - Trunk , et al. May 31, 2
2005-05-31
Capsules containing inhalable tiotropium
App 20050084457 - Hochrainer, Dieter ;   et al.
2005-04-21
Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperid- inyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine
App 20050042179 - Trunk, Michael
2005-02-24
Powder formulation containing the CGRP antagonist 1 [N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2 (1H)-oxoquinazolin-3-yl)-1-piperidi- nyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin, process for preparing and the use thereof as inhalation powder
App 20050042180 - Trunk, Michael ;   et al.
2005-02-24
Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4- -dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-l- ysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder
App 20050042178 - Trunk, Michael ;   et al.
2005-02-24
Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative
App 20050043247 - Trunk, Michael ;   et al.
2005-02-24
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
Grant 6,777,423 - Banholzer , et al. August 17, 2
2004-08-17
Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
App 20040152720 - Hartig, Mareke ;   et al.
2004-08-05
Tiotropium containing powder formulation for inhalation
App 20040136919 - Hartig, Mareke ;   et al.
2004-07-15
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
App 20040087793 - Banholzer, Rolf ;   et al.
2004-05-06
Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof
App 20040014679 - Trunk, Michael ;   et al.
2004-01-22
Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
App 20040002510 - Bender, Helmut ;   et al.
2004-01-01
Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
App 20030191068 - Trunk, Michael ;   et al.
2003-10-09
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
App 20030171586 - Banholzer, Rolf ;   et al.
2003-09-11
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
App 20020169321 - Banholzer, Rolf ;   et al.
2002-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed